Javier P Gisbert
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Digestive Service, Hospital Universitario de La Princesa
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Javier P Gisbert as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:30 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03885713 · Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel DiseaseFundación de Investigación Biomédica - Hospital Universitario de La Princesa · completed · Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis · principal investigator
- N/ANCT02686892 · An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in SpainJavier P. Gisbert · completed · Inflammatory Bowel Disease · principal investigator
- Ph4NCT01273441 · Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical PracticeFundación de Investigación Biomédica - Hospital Universitario de La Princesa · completed · Helicobacter Pylori · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:30 UTC. The ranking covers the 200 most relevant of 63 PubMed records, and a shared surname and initials can bring in a namesake. All 63 on PubMed
- 506 citationsRCR 18.2
- Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance.Gastroenterology · 2013160 citationsRCR 6.9
- Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.Aliment Pharmacol Ther · 2000147 citationsRCR 5.3
- 135 citationsRCR 7.1
- Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.Am J Gastroenterol · 2012128 citationsRCR 4.1
- 105 citationsRCR 5.0
- Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.Aliment Pharmacol Ther · 201099 citationsRCR 4.0
- The stool antigen test for detection of Helicobacter pylori after eradication therapy.Ann Intern Med · 200293 citationsRCR 3.2
- 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.Helicobacter · 200391 citationsRCR 3.0
- Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.Am J Gastroenterol · 200685 citationsRCR 2.8